Int J Food Sci Nutr 2012;63(6):749-765
Am J Pathol 190(1):8292 Zhu M, Chen H, Zhou S, Zheng L, Li X, Chu R, Chen W et al (2021) Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload
Patients should not attempt to combine these medications without explicit guidance from their healthcare provider to ensure safety and efficacy
The lanes labeled 1, 2, 3, and 4 correspond to LMNG/CHS solubilized fraction, anti-FLAG column flow-through, anti-FLAG elution, and purified complex, respectively for both ( c ) and ( d )
10.1111/j.1365-313X.2012.05105.x 16 IqbalN.UmarS.KhanN